在术后胆胸部T9进行有效的胸管结合:一个病例报告
Yusuke Nabe1, Hiroshi Mizuuchi1, Masaaki Inoue1
1Department of Chest Surgery, Shimonoseki City Hospital, Shimonoseki, JPN.
Cureus
|March 5, 2026
概括
手术后的胆胸部可能很难管理. 一种新的技术,包括在T9水平上对脂肪组织进行封锁绑定,成功地治疗了当胸管无法识别时耐火性胸腔.
科学领域:
- 胸部外科手术 胸部外科手术
- 手术并发症 手术并发症
- 胃肠道手术 胃肠道手术
背景情况:
- 手术后的胸是一个罕见但困难的并发症,在肺切除和中枢淋巴结解剖后出现.
- 识别胸腔管道或泄漏点可能具有挑战性,尤其是在胸内粘附或有限资源的情况下.
研究的目的:
- 描述一种替代性手术方法来管理耐火性术后胸.
- 介绍一个案例,在T9水平上使用脂肪组织的阻断绑定来治疗胸,当胸腔管道没有直接识别时.
主要方法:
- 对肺腺癌进行了胸腔镜右上叶切除术与中枢淋巴结解剖.
- 在手术后,尽管经过保守的治疗和使用烯胺,但患者患上了耐火性胆胸.
- 再次手术涉及阻断结合和切除T9水平的脂肪组织,据推测包含胸腔管道.
主要成果:
- 由于严重的胸内粘附和先前的胸膜病变,胸腔管的手术内鉴定受到阻碍.
- 在T9水平上阻断脂肪组织的绑定导致了立即减少状排水.
- 在T9水平绑定手术后,胆胸完全消失,没有复发.
结论:
- 在T9水平上对脂肪组织进行封锁绑定是一种可行且有效的替代方案,用于治疗术后胸腔,当胸腔导管无法识别时.
- 这种技术在显著的胸内粘附或当淋巴血管学无法使用的情况下特别有用.
相关概念视频
Pneumothorax-II
1.2K
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
1.2K
Endoscopic Studies II: Thoracocentesis
1.7K
Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
1.7K


